Angelo Gaffo

5.2k total citations · 2 hit papers
81 papers, 2.6k citations indexed

About

Angelo Gaffo is a scholar working on Nephrology, Surgery and Rheumatology. According to data from OpenAlex, Angelo Gaffo has authored 81 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Nephrology, 34 papers in Surgery and 30 papers in Rheumatology. Recurrent topics in Angelo Gaffo's work include Gout, Hyperuricemia, Uric Acid (57 papers), Case Reports on Hematomas (33 papers) and Urticaria and Related Conditions (13 papers). Angelo Gaffo is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (57 papers), Case Reports on Hematomas (33 papers) and Urticaria and Related Conditions (13 papers). Angelo Gaffo collaborates with scholars based in United States, New Zealand and Japan. Angelo Gaffo's co-authors include Nicola Dalbeth, Abhishek Abhishek, Anna L. Gosling, Jasvinder A. Singh, Kenneth G. Saag, Sebastian E. Sattui, Jeffrey R. Curtis, David R. Jacobs, Ted R. Mikuls and N. Lawrence Edwards and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Angelo Gaffo

74 papers receiving 2.5k citations

Hit Papers

Gout 2020 2026 2022 2024 2021 2020 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Gaffo United States 25 1.7k 741 631 630 461 81 2.6k
Cèsar Díaz‐Torné Spain 30 543 0.3× 1.0k 1.4× 596 0.9× 390 0.6× 276 0.6× 153 2.7k
Miho Shimizu Japan 26 1.2k 0.7× 221 0.3× 281 0.4× 571 0.9× 160 0.3× 121 2.7k
Christopher Wai-Kei Lam Hong Kong 31 1.3k 0.8× 199 0.3× 483 0.8× 459 0.7× 212 0.5× 64 3.2k
Michael S. Lipkowitz United States 30 1.5k 0.9× 128 0.2× 375 0.6× 637 1.0× 259 0.6× 84 2.8k
Haiping Mao China 33 1.6k 0.9× 134 0.2× 495 0.8× 1.2k 2.0× 278 0.6× 132 3.5k
Byung Ha Chung South Korea 32 756 0.4× 142 0.2× 963 1.5× 772 1.2× 209 0.5× 274 3.7k
Alexandre Hertig France 38 1.2k 0.7× 157 0.2× 733 1.2× 837 1.3× 265 0.6× 170 4.2k
Ts’ai-Fan Yű United States 25 1.9k 1.1× 855 1.2× 771 1.2× 857 1.4× 334 0.7× 43 2.8k
Hans Thysell Sweden 26 940 0.6× 587 0.8× 547 0.9× 441 0.7× 118 0.3× 114 3.1k
François Vrtovsnik France 36 1.4k 0.8× 335 0.5× 474 0.8× 665 1.1× 430 0.9× 103 3.5k

Countries citing papers authored by Angelo Gaffo

Since Specialization
Citations

This map shows the geographic impact of Angelo Gaffo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Gaffo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Gaffo more than expected).

Fields of papers citing papers by Angelo Gaffo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Gaffo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Gaffo. The network helps show where Angelo Gaffo may publish in the future.

Co-authorship network of co-authors of Angelo Gaffo

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Gaffo. A scholar is included among the top collaborators of Angelo Gaffo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Gaffo. Angelo Gaffo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stamp, Lisa K., Chris Frampton, Sarah Stewart, et al.. (2025). Relationship Between Gout Flare States and Patient‐Reported Outcomes After Allopurinol Initiation. Arthritis Care & Research. 77(6). 727–731.
2.
Gaffo, Angelo, et al.. (2025). A Review of Gout Flare Management. 11(1).
4.
Gaffo, Angelo, et al.. (2025). Gout therapy updated. Therapeutic Advances in Musculoskeletal Disease. 17. 1759720X251384584–1759720X251384584.
5.
Patel, Aakash V., Sarah Morgan, Ralph Green, et al.. (2024). Vitamin B12 status and hyperhomocysteinemia in patients with Rheumatoid arthritis treated with methotrexate and folic acid. The American Journal of the Medical Sciences. 3 indexed citations
6.
Gaffo, Angelo, et al.. (2024). Paget disease of bone in a southeastern Veteran population. The American Journal of the Medical Sciences. 367(6). 357–362. 1 indexed citations
7.
Gaffo, Angelo, et al.. (2023). Year in Review: Gout Clinical Research. MDPI (MDPI AG). 1(1). 37–48. 3 indexed citations
8.
Topless, Ruth, Ralph Green, Sarah Morgan, et al.. (2022). Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: a case–control analysis from the UK Biobank. BMJ Open. 12(8). e062945–e062945. 6 indexed citations
9.
Gaffo, Angelo, et al.. (2022). Emerging strategies for treating gout. Current Opinion in Pharmacology. 65. 102241–102241. 20 indexed citations
10.
Taylor, William J., Angelo Gaffo, Merryn Gott, et al.. (2021). What Represents Treatment Efficacy in Long-term Studies of Gout Flare Prevention? An Interview Study of People With Gout. The Journal of Rheumatology. 48(12). 1871–1875. 1 indexed citations
11.
Stamp, Lisa K., Ana Beatriz Vargas‐Santos, Mark Fisher, et al.. (2021). Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities. Nature Reviews Rheumatology. 17(10). 633–641. 54 indexed citations
12.
Gaffo, Angelo, Kenneth G. Saag, Anthony Doyle, et al.. (2021). Denosumab did not improve computerized tomography erosion scores when added to intensive urate-lowering therapy in gout: Results from a pilot randomized controlled trial. Seminars in Arthritis and Rheumatism. 51(6). 1218–1223. 3 indexed citations
13.
Colantonio, Lisandro D., Kenneth G. Saag, Jasvinder A. Singh, et al.. (2020). Gout is associated with an increased risk for incident heart failure among older adults: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study. Arthritis Research & Therapy. 22(1). 86–86. 25 indexed citations
14.
Stewart, Sarah, William J. Taylor, Angelo Gaffo, et al.. (2020). The experience of a gout flare: a meta-synthesis of qualitative studies. Seminars in Arthritis and Rheumatism. 50(4). 805–811. 36 indexed citations
15.
England, Bryant R., Harlan Sayles, Geoffrey M. Thiele, et al.. (2019). Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality. Arthritis Care & Research. 72(7). 950–958. 27 indexed citations
16.
Gaffo, Angelo, Nicola Dalbeth, Jasvinder A. Singh, Kenneth G. Saag, & William J. Taylor. (2017). OP0265 Validation of a definition for attack (FLARE) in patients with established gout. Annals of the Rheumatic Diseases. 76. 166–166. 1 indexed citations
17.
18.
Dalbeth, Nicola, Fiona McQueen, Jasvinder A. Singh, et al.. (2011). Tophus Measurement as an Outcome Measure for Clinical Trials of Chronic Gout: Progress and Research Priorities. The Journal of Rheumatology. 38(7). 1458–1461. 17 indexed citations
19.
Taylor, William J., Jasvinder A. Singh, Kenneth G. Saag, et al.. (2011). Bringing It All Together: A Novel Approach to the Development of Response Criteria for Chronic Gout Clinical Trials. The Journal of Rheumatology. 38(7). 1467–1470. 16 indexed citations
20.
Gaffo, Angelo, et al.. (2007). Pulmonary Manifestations of Rheumatoid Arthritis. Seminars in Respiratory and Critical Care Medicine. 28(4). 430–440. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026